Physician

Elizabeth Michelle Volz, MD

According to 2025 Medicare claims, Elizabeth Volz, MD (NPI: 1306012091) practices advanced heart failure and transplant cardiology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is REX HOSPITAL INC (NPI: 1194259432; TIN: 561509260) and primary practice location at 27607-6477. Volz is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Volz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 228 traditional Medicare patients, billed 616 HCPCS/CPT codes, and received $49,498 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,957 prescription claims across 454 beneficiaries totaling $656,223 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 56 claims. Open Payments data shows 27 records totaling $18,511. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,336 to $656,223. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	89	217	$13,498
2016	500	1,303	$69,802
2017	476	13,870	$145,460
2018	800	14,720	$184,556
2019	336	1,260	$96,130
2020	292	996	$73,689
2021	290	904	$75,452
2022	281	778	$73,091
2023	299	816	$74,325
2024	228	616	$49,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	23	$1,336
2016	81	563	$17,339
2017	209	1,134	$51,682
2018	327	2,123	$154,565
2019	321	1,707	$170,027
2020	336	2,202	$221,841
2021	366	2,325	$332,467
2022	363	2,368	$460,574
2023	458	3,034	$730,377
2024	454	2,957	$656,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	19	$1,395
2019	N/R	89	$6,590
2020	N/R	78	$5,013
2021	N/R	64	$4,693
2022	N/R	92	$5,711
2023	N/R	84	$6,030
2024	N/R	56	$4,044

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	52	58	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	37	44	$108
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	68	195	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	57	68	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	52	57	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	342	15,058	$313,939
Jardiance	Empagliflozin	198	10,380	$198,649
Farxiga	Dapagliflozin Propanediol	62	3,208	$57,373
Eliquis	Apixaban	21	1,217	$24,170
Torsemide	Torsemide	228	13,209	$8,680

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	18	$2,337
J1250	Injection, dobutamine hydrochloride, per 250 mg	N	N/R	19	$1,342
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	19	$365

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$3,506	CVRx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$15,005	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Elizabeth Michelle Volz, MD?

Tedicare shows public-source Medicare data for Elizabeth Michelle Volz, MD (NPI 1306012091), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elizabeth Michelle Volz, MD have ACO affiliation data?

Elizabeth Michelle Volz, MD is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Elizabeth Michelle Volz, MD?

Elizabeth Michelle Volz, MD is linked to REX HOSPITAL INC (billing NPI 1194259432) in the available physician profile data.

Does Elizabeth Michelle Volz, MD have Open Payments data?

Elizabeth Michelle Volz, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.